Priorities in Medical Research (PMR) was published in 1988 by a select committee of the House of Lords. The report ushered in an era of NHS research and development (R & D) that lasted from 2001 to 2006. The inquiry's origins lay in concerns about academic medicine in the United Kingdom, yet PMR gave relatively little attention to this subject. Instead the report focused critically on the disconnect between the Department of Health and the NHS in R & D. This, the committee argued, had led to the neglect of research into health services and public health. To sidestep the report's unwelcome proposal for a National Health Research Agency, the department eventually grafted R & D management onto structures created as part of wider NHS reforms. The Medical Research Council successfully pursued a strategy of keeping the committee's attention away from sensitive aspects of its own programme. The final focus of PMR was shaped by an alignment between committee members with an industrial view of research and champions of health services research. The actions of the various actors involved are interpreted using elite models of the state, and the applicability of these models is critically examined.

医学研究的优先事项( PMR ) 于 1988 年由上议院的一个特别委员会出版。在NHS研究与发展（R＆d），持续了从2001年至2006年调查的起源的时代，迎来了本报告躺在英国，但对中医学术的担忧PMR对这个话题的关注相对较少。相反，该报告批判性地关注了卫生部与 NHS 在研发方面的脱节。委员会认为，这导致忽视了对卫生服务和公共卫生的研究。为了回避报告中不受欢迎的国家卫生研究机构提议，该部门最终将研发管理嫁接到作为更广泛 NHS 改革的一部分而创建的结构上。医学研究委员会成功地采取了一种策略，使委员会的注意力远离其自身计划的敏感方面。PMR的最终焦点是由具有行业研究观点的委员会成员和卫生服务研究的拥护者之间的联盟形成的。使用国家的精英模型来解释所涉及的各种行为者的行为，并对这些模型的适用性进行严格审查。